Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 25, Issue 44, Pages 4717-4724Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612825666191022163237
Keywords
Bacterial multidrug resistance; antibiotics; combination therapy; efflux pumps; nanotechnology; infections
Categories
Funding
- Scientific Research Fund of Ministry of Health - Medical Science Major Technology Fund Project of Zhejiang Province [WKJ-ZJ-1609]
Ask authors/readers for more resources
Background: Antibacterial multidrug resistance has emerged as one of the foremost global problems affecting human health. The emergence of resistant infections with the increasing number of multidrug-resistant pathogens has posed a serious problem, which required innovative collaborations across multiple disciplines to address this issue. Methods: In this review, we will explain the mechanisms of bacterial multidrug resistance and discuss different strategies for combating it, including combination therapy, the use of novel natural antibiotics, and the use of nanotechnology in the development of efflux pump inhibitors. Results: While combination therapy will remain the mainstay of bacterial multi-drug resistance treatment, nanotechnology will play critical roles in the development of novel treatments in the coming years. Conclusion: Nanotechnology provides an encouraging platform for the development of clinically relevant and practical strategies to overcome drug resistance in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available